help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barazzone Argiroffo, C.
Right arrow Articles by Piguet, P.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barazzone Argiroffo, C.
Right arrow Articles by Piguet, P.-F.
(American Journal of Pathology. 2002;160:67-71.)
© 2002 American Society for Investigative Pathology

Short Communication

CD40-CD40 Ligand Disruption Does Not Prevent Hyperoxia-Induced Injury

Constance Barazzone Argiroffo*{dagger}, Yves R. Donati*{dagger}, Julien Boccard{dagger}, Anne F. Rochat{dagger}, Christian Vesin{dagger}, Chen-Da Kan{dagger} and Pierre-François Piguet{dagger}

From the Departments of Pediatrics*
and Pathology,{dagger}
University of Geneva Medical School, Geneva, Switzerland

Recent studies suggest that apoptosis plays a role in oxygen-induced injury, although the activation pathways and the executioner proteases that lead to cleavage of lung cell proteins and DNA, are not yet identified. We explored previously the tumor necrosis factor/tumor necrosis factor receptor and the Fas/FasL, belonging to the intrinsic pathway, and could not demonstrate any protective effect by interfering with these cell receptors. Lately, it has been shown that interacting with the CD40 system, also known to promote cell death, by administering anti-CD40 ligand (L) antibody was beneficial in several diseases and, in particular, in hyperoxia-induced injury. Using CD40- and CD40L-deficient mice (-/-) as well as administering anti-CD40L antibody, we examined the extent of lung injury in oxygen-breathing mice by several ways (lung weight, histology, inflammatory mediators, and DNA ladder) as well as the mortality. The development of lung injury was similar in wild-type, CD40-/-, CD40L-/-, or in wild-type mice treated with anti-CD40L antibody. Apoptosis was present in all conditions at 72 hours of oxygen exposure. These results show that oxygen-induced injury does not require CD40-CD40L interaction and that apoptosis of lung cells does not involve this pathway.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Pagano, Y. Donati, I. Metrailler, and C. Barazzone Argiroffo
Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: protection by cyclosporin A
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L275 - L283.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Barazzone-Argiroffo, A. Pagano, C. Juge, I. Metrailler, A. Rochat, C. Vesin, and Y. Donati
Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity
Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L197 - L204.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.